{"id":"https://openalex.org/W2760819643","doi":"https://doi.org/10.1093/annonc/mdx376.003","title":"Interim analysis of the phase 3 ADAPT trial evaluating rocapuldencel-T (AGS-003), an individualized immunotherapy for the treatment of newly-diagnosed patients with metastatic renal cell carcinoma (mRCC)","display_name":"Interim analysis of the phase 3 ADAPT trial evaluating rocapuldencel-T (AGS-003), an individualized immunotherapy for the treatment of newly-diagnosed patients with metastatic renal cell carcinoma (mRCC)","publication_year":2017,"publication_date":"2017-09-01","ids":{"openalex":"https://openalex.org/W2760819643","doi":"https://doi.org/10.1093/annonc/mdx376.003","mag":"2760819643"},"language":"en","primary_location":{"id":"doi:10.1093/annonc/mdx376.003","doi":"https://doi.org/10.1093/annonc/mdx376.003","is_oa":true,"landing_page_url":"https://doi.org/10.1093/annonc/mdx376.003","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://doi.org/10.1093/annonc/mdx376.003","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5050649350","display_name":"Robert A. Figlin","orcid":"https://orcid.org/0000-0002-6323-6075","observed_orcids":["https://orcid.org/0000-0002-6323-6075"]},"institutions":[{"id":"https://openalex.org/I1282927834","display_name":"Cedars-Sinai Medical Center","ror":"https://ror.org/02pammg90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Figlin","raw_affiliation_strings":["Division of Hematology Oncology, Cedars-Sinai Medical Center, Los Angeles, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology Oncology, Cedars-Sinai Medical Center, Los Angeles, CA, USA","institution_ids":["https://openalex.org/I1282927834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107302439","display_name":"Charles A. Nicolette","orcid":"https://orcid.org/0000-0002-2285-9778","observed_orcids":["https://orcid.org/0000-0002-2285-9778"]},"institutions":[{"id":"https://openalex.org/I4210121015","display_name":"Argos Therapeutics (United States)","ror":"https://ror.org/02h9mq080","country_code":"US","type":"company","lineage":["https://openalex.org/I4210121015"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. Nicolette","raw_affiliation_strings":["Research and Development, Argos Therapeutics, Durham, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development, Argos Therapeutics, Durham, NC, USA","institution_ids":["https://openalex.org/I4210121015"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058115259","display_name":"Nizar M. Tannir","orcid":"https://orcid.org/0000-0001-5559-8060","observed_orcids":["https://orcid.org/0000-0001-5559-8060"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"N. Tannir","raw_affiliation_strings":["GU Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GU Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001901126","display_name":"Scott S. Tykodi","orcid":"https://orcid.org/0000-0002-0399-0965","observed_orcids":["https://orcid.org/0000-0002-0399-0965"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S.S. Tykodi","raw_affiliation_strings":["Medical Oncology, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA, USA","institution_ids":["https://openalex.org/I201448701","https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011471503","display_name":"D. Chen","orcid":"https://orcid.org/0000-0002-9788-4310","observed_orcids":["https://orcid.org/0000-0002-9788-4310"]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Chen","raw_affiliation_strings":["Surgical Oncology, Foz Chase Cancer Center, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Surgical Oncology, Foz Chase Cancer Center, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I1289437631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013832255","display_name":"Viraj A. Master","orcid":"https://orcid.org/0000-0002-7251-142X","observed_orcids":["https://orcid.org/0000-0002-7251-142X"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"V. Master","raw_affiliation_strings":["Department of Urology, Emory University, Atlanta, GA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, Emory University, Atlanta, GA, USA","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018745113","display_name":"Brian R. Lane","orcid":"https://orcid.org/0000-0003-1084-1519","observed_orcids":["https://orcid.org/0000-0003-1084-1519"]},"institutions":[{"id":"https://openalex.org/I146183641","display_name":"Spectrum Health","ror":"https://ror.org/02ahxdd04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I146183641","https://openalex.org/I4392738273"]},{"id":"https://openalex.org/I4210096007","display_name":"Corewell Health Blodgett Hospital","ror":"https://ror.org/00qy68j92","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210096007","https://openalex.org/I4392738273"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B. Lane","raw_affiliation_strings":["Urology, Spectrum Health Cancer Center, Grand Rapids, MN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Urology, Spectrum Health Cancer Center, Grand Rapids, MN, USA","institution_ids":["https://openalex.org/I146183641","https://openalex.org/I4210096007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001141587","display_name":"Mark A. Debenedette","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121015","display_name":"Argos Therapeutics (United States)","ror":"https://ror.org/02h9mq080","country_code":"US","type":"company","lineage":["https://openalex.org/I4210121015"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Debenedette","raw_affiliation_strings":["Research and Development, Argos Therapeutics, Durham, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development, Argos Therapeutics, Durham, NC, USA","institution_ids":["https://openalex.org/I4210121015"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044838596","display_name":"Tamara Monesmith","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121015","display_name":"Argos Therapeutics (United States)","ror":"https://ror.org/02h9mq080","country_code":"US","type":"company","lineage":["https://openalex.org/I4210121015"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T. Monesmith","raw_affiliation_strings":["Research and Development, Argos Therapeutics, Durham, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development, Argos Therapeutics, Durham, NC, USA","institution_ids":["https://openalex.org/I4210121015"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015003014","display_name":"Wan Ling Tan","orcid":"https://orcid.org/0000-0002-1744-0008","observed_orcids":["https://orcid.org/0000-0002-1744-0008"]},"institutions":[{"id":"https://openalex.org/I4210121015","display_name":"Argos Therapeutics (United States)","ror":"https://ror.org/02h9mq080","country_code":"US","type":"company","lineage":["https://openalex.org/I4210121015"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"W. Tan","raw_affiliation_strings":["Research and Development, Argos Therapeutics, Durham, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development, Argos Therapeutics, Durham, NC, USA","institution_ids":["https://openalex.org/I4210121015"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046337695","display_name":"Shawn Michael Leland","orcid":"https://orcid.org/0000-0002-8943-204X","observed_orcids":["https://orcid.org/0000-0002-8943-204X"]},"institutions":[{"id":"https://openalex.org/I4210121015","display_name":"Argos Therapeutics (United States)","ror":"https://ror.org/02h9mq080","country_code":"US","type":"company","lineage":["https://openalex.org/I4210121015"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Leland","raw_affiliation_strings":["Research and Development, Argos Therapeutics, Durham, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development, Argos Therapeutics, Durham, NC, USA","institution_ids":["https://openalex.org/I4210121015"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5017537551","display_name":"Christopher G. Wood","orcid":"https://orcid.org/0000-0003-3450-8809","observed_orcids":["https://orcid.org/0000-0003-3450-8809"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C.G. Wood","raw_affiliation_strings":["Urology, UT M.D. Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Urology, UT M.D. Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":9,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5080,"currency":"USD","value_usd":5080},"apc_paid":null,"fwci":0.7445,"has_fulltext":false,"cited_by_count":12,"citation_normalized_percentile":{"value":0.68195673,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"28","issue":null,"first_page":"v404","last_page":"v404"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9086999893188477,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9086999893188477,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.0658000037074089,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.01759999990463257,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-renal-cell-carcinoma","display_name":"metastatic renal cell carcinoma","score":0.8659999966621399},{"id":"https://openalex.org/keywords/tumor-rna","display_name":"tumor RNA","score":0.4429999887943268},{"id":"https://openalex.org/keywords/personalized-immunotherapy","display_name":"personalized immunotherapy","score":0.6819999814033508},{"id":"https://openalex.org/keywords/memory-t-cell-responses","display_name":"memory T cell responses","score":0.7300000190734863},{"id":"https://openalex.org/keywords/intradermal-injection","display_name":"intradermal injection","score":0.6840000152587891},{"id":"https://openalex.org/keywords/newly-diagnosed-patients","display_name":"newly diagnosed patients","score":0.5210000276565552}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9413816928863525},{"id":"https://openalex.org/C61943457","wikidata":"https://www.wikidata.org/wiki/Q6046661","display_name":"Interim analysis","level":3,"score":0.8074324727058411},{"id":"https://openalex.org/C73751289","wikidata":"https://www.wikidata.org/wiki/Q2985397","display_name":"Data monitoring committee","level":3,"score":0.644829273223877},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.6394394636154175},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.6271148920059204},{"id":"https://openalex.org/C2776957806","wikidata":"https://www.wikidata.org/wiki/Q4895105","display_name":"Interim","level":2,"score":0.6139094829559326},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5566356778144836},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5535931587219238},{"id":"https://openalex.org/C2777472916","wikidata":"https://www.wikidata.org/wiki/Q1164529","display_name":"Renal cell carcinoma","level":2,"score":0.5449515581130981},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5026664733886719},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4262024164199829},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.26687902212142944},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.14110401272773743},{"id":"https://openalex.org/C166957645","wikidata":"https://www.wikidata.org/wiki/Q23498","display_name":"Archaeology","level":1,"score":0.0},{"id":"https://openalex.org/C95457728","wikidata":"https://www.wikidata.org/wiki/Q309","display_name":"History","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1093/annonc/mdx376.003","doi":"https://doi.org/10.1093/annonc/mdx376.003","is_oa":true,"landing_page_url":"https://doi.org/10.1093/annonc/mdx376.003","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1093/annonc/mdx376.003","doi":"https://doi.org/10.1093/annonc/mdx376.003","is_oa":true,"landing_page_url":"https://doi.org/10.1093/annonc/mdx376.003","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.800000011920929,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3004420993","https://openalex.org/W2890594281","https://openalex.org/W2138082498","https://openalex.org/W2093762453","https://openalex.org/W2014572103","https://openalex.org/W2322265373","https://openalex.org/W2274374159","https://openalex.org/W2060260809","https://openalex.org/W2732738552","https://openalex.org/W2145888616"],"abstract_inverted_index":null,"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":1}],"updated_date":"2026-10-17T09:40:24.721904","created_date":"2017-10-20T00:00:00"}